expHRD: an individualized, transcriptome-based prediction model for homologous recombination deficiency assessment in cancer
Abstract Background Homologous recombination deficiency (HRD) stands as a clinical indicator for discerning responsive outcomes to platinum-based chemotherapy and poly ADP-ribose polymerase (PARP) inhibitors. One of the conventional approaches to HRD prognostication has generally centered on identif...
Guardat en:
| Autors principals: | , , , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BMC
2024-07-01
|
| Col·lecció: | BMC Bioinformatics |
| Matèries: | |
| Accés en línia: | https://doi.org/10.1186/s12859-024-05854-y |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|
